"10.1371_journal.pone.0117628","plos one","2015-02-23T00:00:00Z","Marietta Rottenkolber; Eef Voogd; Liset van Dijk; Paola Primatesta; Claudia Becker; Raymond Schlienger; Mark C H de Groot; Yolanda Alvarez; Julie Durand; Jim Slattery; Ana Afonso; Gema Requena; Miguel Gil; Arturo Alvarez; Ulrik Hesse; Roman Gerlach; Joerg Hasford; Rainald Fischer; Olaf H Klungel; Sven Schmiedl","Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany; Utrecht Institute for Pharmaceutical Sciences, Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands; Netherlands Institute for Health Services Research, Utrecht, the Netherlands; Novartis Pharma AG, Basel, Switzerland; Division Clinical Pharmacy & Epidemiology, University of Basel, Basel, Switzerland; European Medicines Agency, London, United Kingdom; Pharmacology Unit, Department of Biomedical Sciences II, School of Medicine and Health Sciences, University of Alcalá, Madrid, Spain; BIFAP Unit, Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency for Medicines and Medical Devices, Madrid, Spain; Danish Medicines Agency (Lægemiddelstyrelsen), Medicines Control Division, Copenhagen, Denmark; National Association of Statutory Health Insurance Physicians of Bavaria, Munich, Germany; Medizinische Klinik und Poliklinik V, University Hospital, Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany; Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany; Philipp Klee-Institute for Clinical Pharmacology, HELIOS Clinic Wuppertal, Wuppertal, Germany","Conceived and designed the experiments: MR SS EV CB PP RF YA JS JD RS LVD OHK MDG A. Afonso GR A. Alvarez MG UH JH RG. Wrote the paper: MR SS EV CB PP RF YA JS JD RS LVD OHK MDG A. Afonso GR A. Alvarez MG UH JH RG. Analyzed the data, THIN database: YA JS JD. Analyzed the data, CPRD database: CB PP RS. Analyzed the data, Mondriaan database: EV LVD OHK MDG. Analyzed the data, Bifap database: A. Afonso GR A. Alvarez MG. Analyzed the data, DKMA database: UH. Analyzed the data, Bavarian database: MR SS RG JH RF.","Utrecht University and University of Alcalá received a direct financial contribution from Pfizer and AstraZeneca, respectively, as a special form of the IMI JU grant. LVD reports grants from AstraZeneca (outside the submitted work) and grants from Bristol Myers-Squibb (outside the submitted work); CB reports that her department at the University of Basel received payment from Novartis Pharma AG, Basel, Switzerland, during the conduction of the study for statistical analyses; MDG reports grants from Top Institute Pharma (NL), www.tipharma.com; SS reports personal fees from Rottapharm Madaus (Cologne, Germany, outside the submitted work); PP and RS are employed by Novartis belonging to EFPIA (European Federation of Pharmaceutical Industries and Association) member companies in the IMI JU, and costs related to their part in the research were carried by the respective company as in-kind contribution under the IMI JU scheme. Co-authors Paola Primatesta and Raymond Schlienger are employed by Novartis Pharma AG. Novartis Pharma AG provided support in the form of salaries for authors PP and RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2015","02","Marietta Rottenkolber","MR",20,TRUE,14,NA,3,14,TRUE,FALSE,TRUE,1,"12",FALSE
